224 related articles for article (PubMed ID: 19903806)
21. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study.
Ogilvie GS; Krajden M; van Niekerk DJ; Martin RE; Ehlen TG; Ceballos K; Smith LW; Kan L; Cook DA; Peacock S; Stuart GC; Franco EL; Coldman AJ
Br J Cancer; 2012 Dec; 107(12):1917-24. PubMed ID: 23169286
[TBL] [Abstract][Full Text] [Related]
22. Human Papillomavirus DNA detection for cervical cancer screening.
Press RD
Mol Diagn; 2000 Sep; 5(3):245-7. PubMed ID: 11186127
[No Abstract] [Full Text] [Related]
23. HPV testing alone is not as safe as cytology and selective HPV testing: AGAINST: There is powerful evidence for primary cervical screening.
Kitchener H
BJOG; 2016 Jan; 123(1):68. PubMed ID: 26527427
[No Abstract] [Full Text] [Related]
24. [Impact of HPV testing on cervical cancer screening].
Li G
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):241-5. PubMed ID: 26080933
[No Abstract] [Full Text] [Related]
25. [Management of a low grade smear].
Baldauf JJ; Ritter J
Contracept Fertil Sex; 1999 Apr; 27(4):269-74. PubMed ID: 10349768
[No Abstract] [Full Text] [Related]
26. Extended duration of the detectable stage by adding HPV test in cervical cancer screening.
van den Akker-van Marie ME; van Ballegooijen M; Rozendaal L; Meijer CJ; Habbema JD
Br J Cancer; 2003 Nov; 89(10):1830-3. PubMed ID: 14612887
[TBL] [Abstract][Full Text] [Related]
27. Have we resolved how to triage equivocal cervical cytology?
Solomon D; Schiffman M
J Natl Cancer Inst; 2004 Feb; 96(4):250-1. PubMed ID: 14970266
[No Abstract] [Full Text] [Related]
28. [What strategy should be adopted for the screening of uterine cervix adenocarcinoma? ].
Bourgain C
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S94-5. PubMed ID: 18984317
[No Abstract] [Full Text] [Related]
29. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.
Porras C; Wentzensen N; Rodríguez AC; Morales J; Burk RD; Alfaro M; Hutchinson M; Herrero R; Hildesheim A; Sherman ME; Wacholder S; Solomon D; Schiffman M
Int J Cancer; 2012 Apr; 130(8):1879-87. PubMed ID: 21607948
[TBL] [Abstract][Full Text] [Related]
30. Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial.
Broberg G; Jonasson JM; Ellis J; Gyrd-Hansen D; Anjemark B; Glantz A; Söderberg L; Ryd ML; Holtenman M; Milsom I; Strander B
Int J Cancer; 2013 Jul; 133(1):164-71. PubMed ID: 23233356
[TBL] [Abstract][Full Text] [Related]
31. Comparing cytology, colposcopy and human papillomavirus cervical intraepithelial lesion screening methods in women with systemic lupus erythematosus.
García-Carrasco M; Mendoza-Pinto C; Méndez-Martínez S; Rodríguez-Reyes A; Munguía-Realpozo P; Taboada-Cole A; Vallejo-Ruiz V; Etchegaray-Morales I; Jiménez-Herrera R; Juárez-Melchor D; Villanueva-López I
Lupus; 2020 Aug; 29(9):1060-1066. PubMed ID: 32501171
[TBL] [Abstract][Full Text] [Related]
32. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.
Franco EL
J Natl Cancer Inst Monogr; 2003; (31):89-96. PubMed ID: 12807951
[TBL] [Abstract][Full Text] [Related]
33. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
34. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.
Qiao YL; Sellors JW; Eder PS; Bao YP; Lim JM; Zhao FH; Weigl B; Zhang WH; Peck RB; Li L; Chen F; Pan QJ; Lorincz AT
Lancet Oncol; 2008 Oct; 9(10):929-36. PubMed ID: 18805733
[TBL] [Abstract][Full Text] [Related]
35. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
Schiffman M; Herrero R; Hildesheim A; Sherman ME; Bratti M; Wacholder S; Alfaro M; Hutchinson M; Morales J; Greenberg MD; Lorincz AT
JAMA; 2000 Jan; 283(1):87-93. PubMed ID: 10632285
[TBL] [Abstract][Full Text] [Related]
36. Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3.
Kotaniemi-Talonen L; Anttila A; Malila N; Tarkkanen J; Laurila P; Hakama M; Nieminen P
Eur J Cancer; 2008 Mar; 44(4):565-71. PubMed ID: 18248809
[TBL] [Abstract][Full Text] [Related]
37. Screening for cervical cancer.
Wright TC; Goldie SJ; Cain JM; Howett MK
Science; 2000 Dec; 290(5497):1651. PubMed ID: 11186376
[No Abstract] [Full Text] [Related]
38. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of measuring load of human papillomavirus DNA in cervical samples: an elusive target.
Franco EL; Coutlée F
J Natl Cancer Inst; 2009 Feb; 101(3):131-3. PubMed ID: 19176455
[No Abstract] [Full Text] [Related]
40. Validation of high-risk HPV tests for primary cervical screening.
Meijer CJ; Berkhof H; Heideman DA; Hesselink AT; Snijders PJ
J Clin Virol; 2009 Nov; 46 Suppl 3():S1-4. PubMed ID: 20129067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]